Dr. Sarah Thayer has been appointed by Governor John Bel Edwards to the Louisiana Cancer and Lung Trust Fund Board. The Louisiana Cancer and Lung Trust Fund Board serves to determine policy for the Louisiana Tumor Registry and distribute state funds for cancer research.

Ellen Friday, PhD, Clinical Assistant Professor and Researcher at LSUHS, is among the first 100 people globally to pass the QBRS exam and receive this credential, a distinction among biorepository science professionals.

 The TMIST clinical trial is studying current mammography methods to change the "one size fits all" approach to breast cancer screening.

Dr. Arrigo DeBenedetti receives Spring 2021 Feist Weiller Cancer Center (FWCC) Bridging Award grant in the amount of $100,000.

Bossier Press Tribune - Dr. Sarah Thayer, MD, PhD, FACS has been selected as the next Director of LSU Health Shreveport's Feist Weiller Cancer Center effective February 1, 2021. Dr. Thayer’s role as Director of the Feist-Weiller Cancer Center includes both a clinical leadership role with Ochsner LSU Health Shreveport and a research and medical education leadership role with LSU Health Shreveport.

SHREVEPORT, La. (KSLA) - Cancer patients from across Northwest Louisiana — who are receiving treatment at MD Anderson Cancer Center in Houston — could soon benefit from new trials closer to home.

The Feist-Weiller Cancer Center is excited to be a part of the Cancer Focus Fund to bring the latest new cancer clinical trials to our community," said Dr. Chris Kevil, Vice-Chancellor for Research at LSU Health Shreveport. "We are confident our clinical trial facilities, coupled with expanded patient access to clinical trials across north and central Louisiana in partnership with Ochsner Health, will yield promising results for all citizens of Louisiana.

Dr. Andrew Yurochko shares that in some areas of NW Louisiana, Feist-Weiller's "Partners in Wellness", while focused on mammography and other cancer screening, also provided the only health care available. Now, the program’s three vans offer testing for COVID-19.

Saturday, February 8th, LSU Health Shreveport Faculty continued executing a day of free health screenings at the 4th annual Family Health Day at Feist-Weiller Cancer Center.

Scientists have identified a key gene - eIF4G1 - that shows grade and stage specific upregulation in prostate cancer and is overexpressed and/or amplified in the majority of cases of CRPC.

Since July 1, 2018, 17 new research grants have been awarded to LSU Health Shreveport researchers, totaling more than $14 million dollars in funding.